Emerging discoveries in liquid biomarker research promise to transform the early detection, diagnosis and treatment ...

A paper published in the journal Biomarker Research by a cross-university team led by Queen Mary University of London ...

A Northwestern Medicine study has offered new clues as to why immunotherapy works well for some bladder cancer patients but fails for others, according to a study published in the Journal of Clinical ...

Between 2015 and 2022, men were more likely than women to be diagnosed with regional and/or distant stages of 20 nonreproductive solid cancer types in the United States, according to a study published ...

Metastatic breast cancer subtypes and biomarkers are crucial for guiding treatment decisions and managing disease progression. ER-positive, HER2-negative breast cancer treatment often begins with ...

Biomarker testing in colorectal cancer (CRC) informs doctors about unique features of cancer that may influence its growth, spread, recurrence, and treatment response. Colorectal cancer (CRC), which ...

Gastric cancer remains a leading cause of cancer-related mortality worldwide, owing in part to late diagnosis and heterogeneous clinical behaviour. Prognostic biomarkers that accurately stratify ...

Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and ...

Early detection and prevention of cancer can save lives, but current tools often fall short because of suboptimal accuracy and limited accessibility. The Fred Hutch Cancer Center aims to change that ...

The gut microbiome is no longer viewed as a mere spectator in cancer development – it is increasingly recognized as a key ...